General MedicationsORALStandard

GALANTAMINE HYDROBROMIDE

Standard Dose

4MG/ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Prescription

Summary

Approval overview GALANTAMINE HYDROBROMIDE is listed in Drugs@FDA under application 078185 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient GALANTAMINE HYDROBROMIDE Form and strength SOLUTION;ORAL - 4MG/ML Sponsor HIKMA Submission history Latest submission status date: 2023-11-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview GALANTAMINE HYDROBROMIDE is listed in Drugs@FDA under application 078185 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient GALANTAMINE HYDROBROMIDE Form and strength SOLUTION;ORAL - 4MG/ML Sponsor HIKMA Submission history Latest submission status date: 2023-11-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.